Treatment | Patients |
---|---|
Steroids, number (%) | 100 (100) |
Low dose of steroids monotherapy, number (%) | 4 (4) |
High dose of steroids monotherapy, number (%) | 39 (39) |
Steroid pulse therapy, number (%) | 37 (37) |
sDMARD, number (%) | 55 (55) |
Methotrexate | 43 (43) |
Cyclosporine A | 8 (8) |
Hydroxychloroquine | 4 (4) |
Cyclophosphamide | 2 (2) |
Methotrexate and cyclosporine A | 5 (5) |
Methotrexate and hydroxychloroquine | 2 (2) |
Biologic agents, number (%) | 32 (32) |
Infliximab | 10 (10) |
Tocilizumab | 8 (8) |
Etanercept | 7 (7) |
Anakinra | 6 (6) |
Certolizumab pegol | 1 (1) |
Combination therapy, steroids + sDMARD(s), number (%) | 25 (25) |
Combination therapy, steroids + biologics agent ± sDMARD(s), number (%) | 32 (32) |